Back
Boston Scientific 10K Form
Buy
68
BSX
Boston Scientific
Last Price:
51.35
Seasonality Move:
2.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-05 | 10Q | BSX/Boston Scientific Quarterly |
2020-08-05 | 10Q | BSX/Boston Scientific Quarterly |
2020-05-06 | 10Q | BSX/Boston Scientific Quarterly |
2020-02-25 | 10K | BSX/Boston Scientific Annual |
2019-11-05 | 10Q | BSX/Boston Scientific Quarterly |
2019-07-30 | 10Q | BSX/Boston Scientific Quarterly |
Receive BSX News And Ratings
See the #1 stock for the next 7 days that we like better than BSX
BSX Financial Statistics
Sales & Book Value
Annual Sales: | $12.68B |
---|---|
Cash Flow: | $69M |
Price / Cash Flow: | 62.82 |
Annual Sales: | $12.42 |
Price / Book: | 4.11 |
Profitability
EPS (TTM): | 0.59000 |
---|---|
Net Income (TTM): | $902M |
Gross Margin: | $8.68B |
Return on Equity: | 5.18% |
Return on Assets: | 2.79% |
Boston Scientific Earnings Forecast
Key Boston Scientific Financial Ratios
- The Gross Profit Margin over the past 32 years for BSX is 68.44%.
- The Selling, General & Administrative Expenses for BSX have been equal to 35.64% of Gross Profit Margin.
- The Research & Development expenses have been 10.43% of Revenue.
- The Interest Expense is 67.34% of Operating Income.
- The Net Earning history of BSX is 5.50% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 16 years.
Boston Scientific Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Medical Devices |
Sector: | Healthcare |
Current Symbol: | BSX |
CUSIP: | 101137 |
Website: | bostonscientific.com |
Debt
Debt-to-Equity Ratio: | 0.5 |
---|---|
Current Ratio: | 1.4 |
Quick Ratio: | 0.65 |
Price-to-Earnings
Trailing P/E Ratio: | 113.49 |
---|---|
Forward P/E Ratio: | 23.06 |
BSX Technical Analysis vs Fundamental Analysis
Buy
68
Boston Scientific (BSX)
is a Buy
Is Boston Scientific a Buy or a Sell?
-
Boston Scientific stock is rated a Buy
The current Boston Scientific [BSX] share price is $51.07. The Score for BSX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.